BriaCell Therapeutics Corp.

Dr. Aditya Bardia, Program Director of Breast Medical Oncology at UCLA, commented on BriaCell's recently reported clinical data that highlights the role of the combination of Bria-IMT™ with CPIs in #metastaticbreastcancer. https://bit.ly/4fb75rw

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW; TSX: BCT) is a clinical stage immuno-oncology company that is developing an entirely new class of targeted cellular immunotherapies to transform cancer care. https://bit.ly/3TF7Jn0 #breastcancerawareness #BCAM #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #personalizedcancerimmunotherapies #personalizedcancerdrugs #breastcancer #lungcancer #melanoma #noveldrugs #MBC

If you or someone you know would like to participate in BriaCell’s pivotal Phase 3 clinical study of BriaCell’s lead clinical candidate, Bria-IMT™, in combination with an immune checkpoint inhibitor in #metastaticbreastcancer, please visit: https://bit.ly/4d8P2Sf #breastcancerawareness #BCAM #breastcancer #metastaticbreastcancer #MBC #clinicaltrial #newcancertreatments #innovativecancertreatments #cancertreatments #innovativecancertherapies #clinicalstudy

In BriaCell’s Phase 2 clinical study, patients treated with the same Bria-IMT™ regimen formulation being used in the ongoing Phase 3 pivotal trial experienced a one-year survival rate of 55%. This rate exceeds the survival data of the current standard of care for similar patients (see the image below). https://bit.ly/4fb75rw #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs #breastcancer

Adam M. Brufsky, MD, PhD, FACP, Professor of Medicine at the University of Pittsburgh School of Medicine and Medical Director of the Magee-Women's Cancer Program comments on BriaCell's promising survival data in its Phase 2 study of the Bria-IMT™ regimen. https://bit.ly/4fb75rw #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs #breastcancer

Dr. William V. Williams, BriaCell’s President & CEO, offers insight into the recently reported positive survival data, outperforming patients, and survival rates in BriaCell's Phase 2 #metastaticbreastcancer study. Learn more: https://bit.ly/4fb75rw #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments

BriaCell (Nasdaq: BCTX, BCTXW) (TSX: BCT) announces new positive survival data, outperforming patients, and survival rates in its Phase 2 #metastaticbreastcancer study. For additional information, please visit: https://bit.ly/4fb75rw #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs #breastcancer

On #NationalMammographyDay, we would like to highlight the importance of #breastcancer screening. Increased awareness and early detection can help save lives. BriaCell is dedicated to the fight against breast cancer. https://bit.ly/3MP5wmU #breastcancerawareness #BCAM #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #personalizedcancerimmunotherapies #personalizedcancerdrugs #noveldrugs #MBC #mammography #mammographyawareness

Join us in recognizing Men's #BreastCancerAwareness Week from October 17 to October 23. While this disease is more prevalent in women, it is important to acknowledge that #breastcancer also impacts men. For further details, visit: https://bit.ly/3EwJcKQ #BCAM #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #personalizedcancerimmunotherapies #personalizedcancerdrugs #noveldrugs

35 clinical sites are active and enrolling patients in BriaCell’s pivotal Phase 3 study of Bria-IMT™ combination with immune check point inhibitor in #metastaticbreastcancer. Learn more: https://bit.ly/3Ub3Rfs #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs #breastcancer